Page last updated: 2024-12-07

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(N-(N',N'-dimethylaminoethane)carbamoyl)cholesterol: used to prepare sonicated liposomes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115234
SCHEMBL ID5884196
MeSH IDM0192259

Synonyms (26)

Synonym
dc-chol
3-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
137056-72-5
3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
cholest-5-en-3-ol (3beta)-, (2-(dimethylamino)ethyl)carbamate
dac 30
dac-30
cholesteryl n-(2-dimethylaminoethyl)carbamate
3beta-[n-(n',n'-dimethylaminoethane)-carbamoyl]cholesterol
AKOS025294423
SCHEMBL5884196
(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl (2-(dimethylamino)ethyl)carbamate
J-006956
3beta-{n-[2-(dimethylamino)ethyl]carbamoyl}cholesterol
3-beta-cholest-5-en-3-yl [2-(dimethylamino)ethyl]carbamate
NCGC00485229-01
3beta-[n-(n',n'-dimethylaminoethane)- carbamoy1]cholesterol
HIHOWBSBBDRPDW-PTHRTHQKSA-N
3beta-[n-(n',n'-dimethylaminoethane)carbamoyl]cholesterol
cholest-5-en-3-yl hydrogen [2-(dimethylamino)ethyl]carbonimidate
DTXSID80929700
3|a-[n-(n',n'-dimethylaminoethane)-carbamoyl]cholesterol
o-[(n,n-dimethylaminoethyl)-carbamoyl]cholesterol
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate
3 beta -{n-[2-(dimethylamino)ethyl]carbamoyl}cholesterol
cholest-5-en-3-ol (3beta)-, [2-(dimethylamino)ethyl]carbamate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The safe and efficient delivery of nucleic acids into haematopoietic stem cells (HSCs) has a wide range of therapeutic applications."( KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells.
Clément, JC; Delépine, P; Férec, C; Fichou, Y; Hardy, E; Le Bris, M; Le Ny, K; Montier, T; Picquet, E; Yaouanc, JJ, 2004
)
0.32
"We developed binary and ternary complexes based on polymers and liposomes for safe and effective delivery of small interfering RNA (siRNA)."( Safe and effective delivery of small interfering RNA with polymer- and liposomes-based complexes.
Harauchi, S; Higuchi, N; Ichikawa, N; Kawanabe, S; Kitahara, T; Kodama, Y; Muro, T; Nakagawa, H; Nakamura, T; Sasaki, H, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
" Intranasal vaccination with ovalbumin (OVA) in combination with DOTAP/DC-chol liposomes induced the production of OVA-specific IgA in nasal tissues and increased serum IgG1 levels, suggesting that the cationic DOTAP/DC-chol liposome leads to the induction of a Th2 immune response."( Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Aramaki, Y; Hidaka, A; Honjo, E; Iwase, N; Iwata, T; Kiyono, H; Kunisawa, J; Muto, S; Sato, E; Tada, R; Takahashi, S; Takayama, N; Yamakita, Y, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Optimal dosage of injected DNA was from 30 to 70 micrograms per tumor."( Direct gene transfer to mouse melanoma by intratumor injection of free DNA.
Huang, L; Yang, JP, 1996
)
0.29
" Subcutaneous liposome-mediated DNA immunisation employing two DRV(DNA) formulations as well as naked DNA revealed that humoural responses (immunoglobulin total IgG, and subclasses IgG1 and 1gG2a) engendered by the plasmid encoded NP were substantially higher after dosing twice, 28 days apart with 10 microg liposome-entrapped DNA compared to naked DNA."( Liposome-mediated DNA immunisation via the subcutaneous route.
McNeil, S; Perrie, Y; Vangala, A, 2003
)
0.32
" Formulation with 3beta [N-(N', N'-dimethylaminoethane) carbamoy] cholesterol (DC-Chol) DC-cholesterol (DC-Chol))/DOPE or dexamethasone in the first dosing at day 0 resulted in moderate alkaline phosphatase expression at day 24."( Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration.
Diamond, SL; Limberis, MP; Price, AR; Wilson, JM, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (115)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's32 (27.83)18.2507
2000's43 (37.39)29.6817
2010's37 (32.17)24.3611
2020's3 (2.61)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.70 (24.57)
Research Supply Index4.80 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (3.42%)5.53%
Reviews1 (0.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other112 (95.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]